Glucagon-like Peptide-1 Receptor-based Therapeutics for Metabolic Liver Disease
{{output}}
Glucagon-like peptide-1 (GLP-1) controls islet hormone secretion, gut motility, and body weight, supporting development of GLP-1 receptor agonists (GLP-1RA) for the treatment of type 2 diabetes (T2D) and obesity. GLP-1RA exhibit a favorable safety profile and ... ...
